Clinical

The image shows both company logos of Indica Labs and Source LDPath showcasing the partnership. Since deploying HALO AP® at its Nottingham headquarters, Source BioScience has processed approximately 78,000 cases and 278,000 slides in under nine months with a national rollout now underway that will significantly expand digital pathology capacity across the UK’s outsourced histopathology market.

Source BioScience Selects Indica Labs’ HALO AP® as the Digital Pathology Platform Powering the Future of NHS Outsourcing in the United Kingdom

HALO AP, News, Press Releases / , , , ,

Albuquerque, NM, and Nottingham, September 8, 2026 – Indica Labs, the trusted global leader in AI-powered digital pathology and Source Bioscience, the United Kingdom’s leading provider of histopathology services, today announced Source Bioscience’s successful expansion of its digital pathology operation powered by HALO AP®. Since going live at Nottingham headquarters in October 2025, the organization has demonstrated how an interoperable, scanner-agnostic enterprise platform can eliminate one of the greatest barriers to large-scale digital pathology outsourcing while enabling rapid laboratory growth.

Source BioScience Selects Indica Labs’ HALO AP® as the Digital Pathology Platform Powering the Future of NHS Outsourcing in the United Kingdom Read More »

Leica Biosystem and Indica Labs combined Aperio HALO AP DX and Aperio GT 450 DX Scanner for a complete clinical digital pathology ecosystem

Leica Biosystems and Indica Labs Expand Digital Pathology-Powered Diagnostics in the USA with Aperio HALO AP DX Software Launch

HALO AP, HALO AP Dx, News, Press Releases / , , ,

Vista, CA, and Albuquerque, NM, March 31, 2026 – Leica Biosystems, a Danaher company and a global leader in anatomic and digital pathology solutions, and Indica Labs, a global leader in artificial intelligence (AI)-powered digital pathology software, launches Aperio HALO AP DX image management system designed for use with the Aperio GT 450 DX scanner. Together, the Aperio HALO AP DX software and the Aperio GT 450 DX scanner provide a complete, integrated clinical digital pathology solution supporting on‑screen diagnostics across routine pathology workflows in the USA.

Leica Biosystems and Indica Labs Expand Digital Pathology-Powered Diagnostics in the USA with Aperio HALO AP DX Software Launch Read More »

HALO AP® earned 94.9/100* for overall customer rating in the 2026 Best in KLAS Awards - Global Software report for digital pathology.

KLAS Recognition as a Catalyst for What Comes Next

Blogs, HALO AP, News / ,

We are proud to mark a significant milestone: HALO AP® earned the highest overall customer rating in the 2026 KLAS Global Software report for digital pathology. Because KLAS distinction is driven entirely by direct customer feedback, this recognition reflects the real-world performance, reliability, and impact of our platform in daily pathology practice.

KLAS Recognition as a Catalyst for What Comes Next Read More »

Breast Macrodissect AI accurately identifies ductal carcinoma in situ (DCIS) and excludes this non-invasive region from invasive tumor analysis. Demonstrating the algorithm’s ability to differentiate between clinically relevant tissue architecture and improving molecular testing in breast cancer.

Indica Labs Sets New Standard for Molecular Testing in Breast Cancer with Expansion of AI Macrodissection Portfolio

Clinical, HALO AP, HALO Clinical AI, HALO Macrodissect Solutions, News, Press Releases / , , , ,

Albuquerque, NM, February 10, 2026 – Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced the expansion of its macrodissection portfolio with the launch of Breast Macrodissect AI . The suite now includes advanced algorithms for non-small cell lung cancer (NSCLC), colorectal cancer (CRC), and breast cancer, with prostate cancer planned for release in early 2026.

Indica Labs Sets New Standard for Molecular Testing in Breast Cancer with Expansion of AI Macrodissection Portfolio Read More »

Indica Labs, HALO AP Dx, FDA 510(k)-cleared digital pathology platform displayed with the Aperio GT 450 DX Scanner for in vitro diagnostic use.

Indica Labs Receives FDA Clearance for Enterprise Digital Pathology Platform with Industry Leading DICOM-Compatible Aperio Scanner from Leica Biosystems

Clinical, HALO AP, HALO AP Dx, News, Press Releases / , ,

ALBUQUERQUE, NM, and VISTA, CA, December 3, 2025 – Indica Labs, the global leader of AI-powered digital pathology, and Leica Biosystems, a global leader in anatomic and digital pathology solutions, announced today that the Food and Drug Administration (FDA) has issued a 510(k) clearance for the enterprise digital pathology platform HALO AP Dx in conjunction with Leica Biosystems Aperio GT 450 DX Scanner for in-vitro diagnostic use.

Indica Labs Receives FDA Clearance for Enterprise Digital Pathology Platform with Industry Leading DICOM-Compatible Aperio Scanner from Leica Biosystems Read More »

An Automated Clinical Workflow Integrating an AI-driven PD-L1 22C3 Scoring Algorithm into a Browser-Based Digital Pathology Solution

Abstracts/Posters, Literature / , , , , , , ,

Discover how Guardant Health has seamlessly integrated Lunit SCOPE PD-L1 with HALO AP® for enhanced PD-L1 analysis.

An Automated Clinical Workflow Integrating an AI-driven PD-L1 22C3 Scoring Algorithm into a Browser-Based Digital Pathology Solution Read More »

Free Demo
Free Demo
Scroll to Top